Evicenter
Trulicity (dulaglutide) in Type 2 diabetes
Manufacturer
Eli Lilly and Company
Prescribing information
Trulicity (opens in a new tab)
Questions
44
Last updated

All questions

Specific populations: Trulicity (dulaglutide) in type 2 diabetes

3 questions · 1 source

Specific populations

At what age can children use Trulicity?

Applies to Glycemic control as an adjunct to diet and exercise in pediatric patients 10 years of age and older with type 2 diabetes mellitus

Pediatric use

How much does Trulicity lower A1C in children 10 and older?

Applies to Glycemic control as an adjunct to diet and exercise in pediatric patients 10 years of age and older with type 2 diabetes mellitus

“Table 15: Glycemic Results at Week 26 in Pediatric Patients 10 Years of Age and Older with Type 2 Diabetes Mellitus with Inadequate Glycemic Control Despite Diet and Exercise (With or Without Metformin and/or Basal Insulin) Abbreviations: HbA1c = hemoglobin A1c. a Combined results for TRULICITY 0.75 mg and 1.5 mg. The comparison of the two dosages together and individually with placebo was prespecified with overall type I error controlled. b The change from baseline and difference from placebo were analyzed using analysis of covariance with effects for treatment, the baseline value as a covariate, and stratification factors which were HbA1c at screening (< 8% vs >= 8%), insulin use at baseline (yes/no), metformin use at baseline (yes/no). c For HbA1c and Fasting Blood Glucose, multiple imputation was performed for missing data guided by washout method. At Week 26 primary efficacy (HbA1c) was missing for 8%, 6%, and 10% of patients on placebo, TRULICITY 0.75 mg and TRULICITY 1.5 mg respectively. d For percentage of patients HbA1c < 7%, missing data was imputed as not achieving the target. Placebo TRULICITY 0.75 mg once weekly TRULICITY 1.5 mg once weekly TRULICITY once weekly Pooleda Intent-to-Treat Population (N) 51 51 52 103 HbA1c (%) (Mean)c Baseline Change from baseline at Week 26b Difference from placebo (95% CI)b 8.1 0.6 - 7.9 -0.6 -1.2 (-1.8, -0.6) 8.2 -0.9 -1.5 (-2.1, -0.9) 8.0 -0.8 -1.4 (-1.9, -0.8) Percentage of Patients with HbA1c <7.0% at Week 26d 14% 55% 48% 52% Fasting Blood Glucose (mg/dL) (Mean)c Baseline Change from baseline at Week 26b Difference from placebo (95% CI)b 159 17.1 - 149 -12.8 -29.9 (-50.7, -9.1) 163 -24.9 -42.0 (-63.0, -20.9) 156 -18.9 -35.9 (-54.2, -17.6)” (opens the source at this quote in a new tab)

Note: Table 15 columns are placebo, TRULICITY 0.75 mg, TRULICITY 1.5 mg, and the pooled TRULICITY group. In the HbA1c and fasting blood glucose rows the label lists, for each column in turn, the baseline value, the change from baseline at Week 26, and the difference from placebo.

What are the side effects of Trulicity in children?

Applies to Glycemic control as an adjunct to diet and exercise in pediatric patients 10 years of age and older with type 2 diabetes mellitus